ICON

Digital

Precision medicine meets machine learning: AI and oncology b...

A close examination of the current and future role of AI in biomarker discovery and the challenges that developers face in leveraging it.

Patients

Outcome measures: Patients beyond endpoints

Pharmaceutical companies face increasing pressure to demonstrate not only the efficacy of their treatments, but also the impact of these treatments on patients' lives.

Digital

Measuring-the-cost-effectiveness-of-vaccines-DeepDive

How cost-effective are infectious disease vaccines?

Cost-effectiveness modelling is a powerful tool in understanding the value health interventions can bring to populations.

R&D

Using cross-functional teams to develop a product’s value st...

Tanya Brinsden, senior VP of operations at ICON Global Medical Communications and Pubs Hub, Jessica Cherian, VP of content and strategic services at ICON Market Access and Reimbursement, an

Deep Dive

Recruiting patients to increase diversity & inclusion in cli...

More so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering momentum within the clinical trial community.

Sales & Marketing